Pollen Pharma Private Limited
About Pollen Pharma Private Limited
Data last updated:
Pollen Pharma Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2009PTC021634. Its GSTIN is 23AAECP9678E1Z5 (Madhya Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vishnu Tamrakar and Rajendra Kumar Tamrakar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 389 Nav Adarsh Colony Garha Road, Jabalpur, Madhya Pradesh, India – 482002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹3.49 Lakh (net margin 2.2%) and EBITDA of ₹5.66 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 4% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pollen Pharma Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address389 Nav Adarsh Colony Garha Road, Jabalpur, Madhya Pradesh, India – 482002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pollen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pollen Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pollen Pharma Private Limited, buy the company report.
Financials of Pollen Pharma Private Limited
FY 2025 filings availablePollen Pharma Private Limited reported revenue of ₹1.55 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 1% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pollen Pharma Private Limited, buy the company report.
Board of directors of Pollen Pharma Private Limited
Pollen Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnu Tamrakar | Director | 19 Feb 2009 | 17 Years 8 Months | Current |
| Rajendra Kumar Tamrakar | Director | 19 Feb 2009 | 17 Years 8 Months | Current |
Peer comparison
Pollen Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ginsburg Drugs and Formulations Private Limited | ₹1.56 Cr (FY 2024) | -1.0% | Gorakhpur, Uttar Pradesh, India | |||
| Euromedicare International Private Limited | ₹1.56 Cr (FY 2025) | -4.0% | Hyderabad, Telangana, India | |||
| Kelly Pharmaceuticals Private Limited | ₹1.56 Cr (FY 2024) | 19.0% | Uttam Nagar, New Delhi, Delhi, India | |||
| Pollen Pharma Private Limitedthis company | ₹1.55 Cr (FY 2025) | ₹3.49 Lakh | 2.2% | 1.0% | Jabalpur, Madhya Pradesh, India | |
| Sayas Pharma Private Limited | ₹1.55 Cr (FY 2024) | 197.0% | Pune, Maharashtra, India |
To see the full peer comparison of Pollen Pharma Private Limited, buy the company report.
Auditor
Pollen Pharma Private Limited is audited by K C A & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K C A & ASSOCIATES | FY 2020 | 008844C |
Shareholding
The shareholding of Pollen Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pollen Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pollen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pollen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pollen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECP9678E1Z5 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pollen Pharma Private Limited, buy the company report.
Recent activity
Pollen Pharma Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Shashikant Singh ceased to be Director on 02 Jul 2018.
Frequently asked questions
Pollen Pharma is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2009 (17+ years old) and is registered under CIN U24232MP2009PTC021634.
Pollen Pharma has 2 current directors:
- Vishnu Tamrakar - Director
- Rajendra Kumar Tamrakar - Director
The latest financial statements of Pollen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pollen Pharma is 23AAECP9678E1Z5, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Pollen Pharma is U24232MP2009PTC021634. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pollen Pharma was incorporated on 19 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Pollen Pharma by revenue are Ginsburg Drugs and Formulations Private Limited, Euromedicare International Private Limited, Kelly Pharmaceuticals Private Limited, Sayas Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Shashikant Singh ceased to be Director on 02 Jul 2018. Rajendra Kumar Tamrakar was appointed as Director on 19 Feb 2009. Vishnu Tamrakar was appointed as Director on 19 Feb 2009.
The registered office of Pollen Pharma is at 389 Nav Adarsh Colony Garha Road, Jabalpur, Madhya Pradesh, India – 482002.
Pollen Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Pollen Pharma is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
